Applied Value Group Announces the Sale of Platform Investment, Division 5, to Rodgers Metal Craft
Applied Value Group (“AVG”), a leading investment, management consulting, and social impact group, announced that its platform investment, Division 5 LLC (“Division 5”), has been acquired by Rodgers Metal Craft, Inc. (“Rodgers”).
Headquartered in Winston, GA, Division 5 is a fully integrated structural and miscellaneous steel fabricator with national reach. Founded by Bryan Hill and Rhonda Wylie in 2001, Division 5 has become a leader through its commitment to on-time delivery and superior quality. Clients across multiple industries depend on Division 5 to build critical supply chain, data center and public infrastructure.
After purchasing Division 5 in 2018, AVG partnered with the management team to transform Division 5 into one of the largest structural and miscellaneous steel fabricators in the Southeastern United States. In 2020, Division 5 completed its acquisition of Structural Steel of Carolina (“SSC”), cementing its position as a leader in the region.
Division 5’s management team will retain ownership in the company and looks forward to supporting Rodgers in continuing to build a leading, world-class structural and miscellaneous steel fabricator. Together, Rodgers and Division 5 will combine for 600,000+ square feet of production space, enabling the company to handle single jobs of up to 30,000 tons.
Bryan Hill, CEO of Division 5, said, “The combination of Division 5 with Rodgers marks the culmination of a successful six-year journey with AVG. Our acquisition of SSC expanded our geographical reach, and we invested in our manufacturing capabilities to enable the continued evolution of our best-in-class production systems and customer service. We look forward to continuing to serve our longstanding customers on nationwide projects with our improved capabilities.”
Rhonda Wylie, Division 5’s CFO, expressed her appreciation for the partnership between Division 5 and AVG, “With AVG’s hands-on strategic and operational support, and through close collaboration with AVG’s management consultancy, we have been able to grow Division 5 profitably to become a leading player in structural and miscellaneous steel fabrication. We thank AVG for their partnership on this journey.”
"We are thrilled to have found a great partner for Division 5 in Rodgers," said Bruce Grant, Executive Chairman of AVG. "This transaction aligns with our strategic focus on investing in and developing companies with our Lean Growth framework to deliver exceptional value.” Maximillian Sultan, a Partner with AVG, added “We thank Bryan, Rhonda, and the rest of the Division 5 team for their partnership over the years and wish them the best in their next phase of growth.” Ryan Huff, Applied Value's Consulting CEO, commented, “Rodgers shares Division 5’s dedication to quality and innovation, and we believe they are well-positioned to reach new heights together."
Truist Securities served as exclusive financial advisor to Division 5 and AVG. Terms of the transaction were not disclosed.
About Applied Value Group: Founded in 1997 by Executive Chairman Bruce Grant, Applied Value Group is a global investment, management consulting, and social impact group. With decades of experience growing and transforming organizations through hands-on value creation, Applied Value Group companies leverage group consulting resources to accelerate growth and implement operational improvements. Applied Value Group has made more than 50 total investments across industries, and has offices in New York, Miami, Stockholm, and Shanghai.
About Division 5 LLC: Division 5 is a full-service structural and miscellaneous steel fabricator based in Winston, GA. Founded in 2001, Division 5 has five manufacturing plants totaling 350,000 square feet. Division 5 can fabricate 50,000 tons of steel per year across its facilities. Division 5 is an established supplier nationally for all types of buildings, ranging from warehouses to refrigerated distribution centers, manufacturing plants, schools and public buildings, data centers, and more.
About Rodgers Metal Craft, Inc.: Headquartered in Fortson, GA, Rodgers is a family-owned and operated heavy structural and miscellaneous steel fabricator with project experience in 46 states, including Puerto Rico. Rodgers partners with an established general contractor network that leads large-scale construction projects across both public and private markets, including education, distribution centers, and industrial facilities. Founded in 1969, Rodgers has the capacity to fabricate 61,000 tons per year across 305,000 square feet of production space.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240606230353/en/
Contact information
John Catapano
Email: john.catapano@appliedvalue.com
Phone: +1 978 430 9761
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Seoul Semiconductor: Philips Lighting Products Ordered to Recall 7-Year-Old Items26.12.2024 08:00:00 CET | Press Release
The German District Court of Düsseldorf, on November 19 ruled in favor of Seoul Semiconductor (KOSDAQ:046890) in the patent infringement lawsuits, and also ordered that products manufactured by Philips Lighting and sold since March 2017 be recalled and destroyed. The Court also ruled that a fine of up to €250,000 would be imposed for each violation of this order. On December 17, the German Federal Patent Court also affirmed the validity of these patents, which solidifies the strength of many related patents. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241225151382/en/ Application Examples with CRI 70 or Higher (Photo: Seoul Semiconductor) These court orders relate to the core technology used to achieve CRI 70 (Color Rendering Index 70%) or higher, applicable to all home lighting, automotive lighting products, IT flash, and backlights. Since the effects of these judgments are applicable to all products infringing on the pa
ispace-EUROPE and the Italian Space Agency (ASI) Sign Payload Services Agreement to Transport a Laser Retroreflector Array (LaRA2) on the Moon Surface26.12.2024 08:00:00 CET | Press Release
ispace EUROPE S.A. (ispace-EUROPE), the Luxembourg-based subsidiary of ispace, inc., and the Italian Space Agency (ASI) have signed a payload services agreement to transport a Laser Retroreflector Array (LaRA2) to enable accurate position measurements on the Moon via laser ranging experiments, the two organizations announced today. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241225137548/en/ The shape of LaRA2, a palm-sized dome (Photo: Business Wire) The agreement marks the first full-scale contract between ispace-EUROPE and ASI, with both organizations looking to joint future lunar development. LaRA2 is a small, robust, and lightweight instrument built to work without any power source and to survive the harsh surface conditions on the Moon for an extended period of time. It features a precise array of retroreflectors (corner cube prisms) designed to reflect laser beams directly back to their source, regardless of the an
Datopotamab Deruxtecan Application in the EU for Patients with Advanced Nonsquamous Non-Small Cell Lung Cancer Voluntarily Withdrawn24.12.2024 08:00:00 CET | Press Release
Daiichi Sankyo (TSE: 4568) and AstraZeneca (LSE/STO/Nasdaq: AZN) have voluntarily withdrawn the marketing authorization application (MAA) in the EU for datopotamab deruxtecan (Dato-DXd) for the treatment of adult patients with locally advanced or metastatic nonsquamous non-small cell lung cancer (NSCLC) based on the TROPION-Lung01 phase 3 trial. The decision to withdraw the MAA was informed by feedback from the Committee for Medicinal Products for Human Use of the European Medicines Agency (EMA). Daiichi Sankyo and AstraZeneca will continue to work to bring datopotamab deruxtecan to patients with lung cancer in the EU who can benefit and are committed to unlocking the potential of this medicine in lung cancer through our robust clinical development program which includes seven pivotal trials in various lung cancer settings. Datopotamab deruxtecan is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo and being jointly developed by Dai
Vertex to Present at the 43rd Annual J.P. Morgan Healthcare Conference on January 1323.12.2024 22:05:00 CET | Press Release
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that Dr. Reshma Kewalramani, Chief Executive Officer and President, will present at the 43rd Annual J.P. Morgan Healthcare Conference on Monday, January 13, 2025 at 10:30 a.m. ET/7:30 a.m. PT. A live webcast of management's remarks will be available through the Vertex website, www.vrtx.com in the "Investors" section under the "News and Events" page. A replay of the conference webcast will be archived on the company's website. About Vertex Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious diseases. The company has approved medicines that treat the underlying causes of multiple chronic, life-shortening genetic diseases — cystic fibrosis, sickle cell disease and transfusion-dependent beta thalassemia — and continues to advance clinical and research programs in these diseases. Vertex also has a robust clinical pipeline of investigational
Perma-Pipe International Holdings, Inc. Announces Third Quarter Financial Results23.12.2024 18:43:00 CET | Press Release
Perma-Pipe International Holdings, Inc. (NASDAQ: PPIH) announced today financial results for the second quarter and fiscal year-to-date period ended October 31, 2024. "Net sales for the third quarter were $41.6 million, a decrease of $4.1 million, as compared to the same quarter last year. Net income attributable to common stock of $2.5 million was an increase of $0.5 million, or 29%, compared to $1.9 million in the third quarter of 2023. For the nine months ended October 31, 2024, net sales of $113.4 million represent an increase of 3% compared to the nine months ended October 31, 2023. The net income attributable to common stock of $7.2 million was an increase of $5.4 million, or 294%, compared to net income attributable to common stock of $1.8 million in the nine months ended October 31, 2023,” noted President and CEO David Mansfield. “Backlog in the third quarter shows considerable growth and now stands at $114.2 million. This is the equivalent to approximately nine months revenue
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom